1. AB0341 Favorable Effects of Sirukumab Treatment on Physical Function and Reductions in Morning Stiffness in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Disease-Modifying Anti-Rheumatic Drugs. (15th July 2016) Authors: Thorne, C.; Takeuchi, T.; Karpouzas, G.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0378 Improvements in Measures of Work Productivity/interference and General Health Status with Sirukumab Treatment in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment. (15th July 2016) Authors: Takeuchi, T.; Karpouzas, G.; Thorne, C.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES. (2nd June 2020) Authors: Mcgonagle, D.; Mcinnes, I.; Deodhar, A.; Schett, G.; Mease, P. J.; Shawi, M.; Kafka, S.; Karyekar, C.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Sheng, S.; Agarwal, P.; Zhou, B.; Ritchlin, C. T.; Rahman, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0813 GUSELKUMAB-TREATED PATIENTS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENT IN SYSTEMIC SYMPTOMS AS MEASURED WITH PROMIS INSTRUMENT: RESULTS FROM PHASE-3 PSORIATIC ARTHRITIS TRIAL DISCOVER 1. (2nd June 2020) Authors: Orbai, A. M.; Coates, L. C.; Deodhar, A.; Helliwell, P.; Ritchlin, C. T.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Sheng, S.; Zhou, B.; Han, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical comparison of superior thyroid artery perforator flap and sternocleidomastoid myocutaneous flap for intraoral reconstruction. Issue 3 (March 2023) Authors: Ma, C.; Sheng, S.; Gao, W.; Haugen, T.; Zhu, Y.; Shen, Y. Journal: International journal of oral & maxillofacial surgery Issue: Volume 52:Issue 3(2023) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Emission computed tomography for the diagnosis of madnibular invasion by head and neck cancers: a systematic review and meta-analysis. (October 2015) Authors: Sheng, S.; Li, C.; Pan, J.; Li, L. Journal: International journal of oral & maxillofacial surgery Issue: Volume 44(2015)Supplement 1 Page Start: e287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0181 Sirukumab, a human anti-IL-6 monoclonal antibody, improves physical function in patients with active ra despite methotrexate therapy: Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study. (23rd January 2014) Authors: Hsu, B.; Chiou, C.-F.; Sheng, S.; Smolen, J.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS. (2nd June 2020) Authors: Rahman, P.; Ritchlin, C. T.; Helliwell, P.; Boehncke, W. H.; Mease, P. J.; Gottlieb, A. B.; Kafka, S.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Shawi, M.; Sheng, S.; Agarwal, P.; Zhou, B.; Ramachandran, P.; Mcinnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0025 Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. (23rd January 2014) Authors: Hsu, B.; Sheng, S.; Weinblatt, M.E.; Smolen, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES. (2nd June 2020) Authors: Helliwell, P.; Gladman, D. D.; Poddubnyy, D.; Mease, P. J.; Baraliakos, X.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Sheng, S.; Agarwal, P.; Zhou, B.; Chakravarty, S. D.; Shawi, M.; Karyekar, C.; Deodhar, A.; Van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗